subgroup analyzes

Related by string. Subgroup analyzes * subgroups . Subgroup . Subgroups : economically disadvantaged subgroup . economically disadvantaged subgroups . demographic subgroups . Bayer HealthCare subgroup . subgroups Bayer HealthCare . discrete subgroups / Analyze . Analyzes . ANALYZE : Find Compare Analyze . collects analyzes . statistical analyzes . analyze nucleic acids . meta analyzes * *

Related by context. Frequent words. (Click for all words.) 69 placebo controlled trials 68 randomized trials 68 RCTs 68 substudy 66 randomized clinical trials 65 meta analyzes 65 FDG PET 65 observational studies 65 adjuvant therapy 64 epidemiologic studies 64 generalizability 64 randomized clinical 64 randomized controlled trials 64 antiplatelet therapy 63 carotid stenting 62 comorbid conditions 62 comorbidities 62 meta analysis 62 randomized Phase III 62 prognostic factors 62 thromboembolic events 62 prespecified 61 adjuvant chemotherapy 61 efficacy endpoints 61 Phase 2b study 61 prospective randomized 60 hepatotoxicity 60 randomized controlled clinical 60 longitudinal studies 60 composite endpoint 60 left ventricular dysfunction 60 unblinded 60 antihypertensive drugs 60 bosentan 60 confounders 60 nesiritide 60 pharmacodynamic 60 CA4P 60 multivariate analysis 60 dose escalation 60 dosing regimens 60 chemoradiation 60 PCa 60 vicriviroc 59 randomized controlled trial 59 vertebral fracture 59 reach statistical significance 59 post hoc 59 Phase 2a trial 59 Pharmacokinetic 59 covariates 59 nonresponders 59 randomized controlled 59 statin therapy 59 coronary angiography 59 Secondary endpoints 59 clinical endpoints 59 phase IIb 59 myocardial infarctions 59 multicentre 59 liver metastases 59 thromboembolism 59 multicenter study 59 phase IIa 59 rosuvastatin 58 Conclusions 58 abciximab 58 adalimumab 58 vitamin D supplementation 58 stent implantation 58 myocardial ischemia 58 multicenter 58 PROMACTA 58 tamsulosin 58 postoperative complications 58 echocardiographic 58 temsirolimus 58 cardiovascular morbidity 58 epidemiological studies 58 renal dysfunction 58 CYPHER ® Stent 58 secondary endpoints 58 Phase Ib 58 FOLFIRI 58 PXD# 58 dose cohorts 58 azacitidine 58 phase 2a 58 comorbidity 58 sunitinib 58 abatacept 57 antihypertensive medications 57 teriparatide 57 tocilizumab 57 vitro studies 57 lipid lowering 57 hsCRP 57 histologic 57 randomized placebo controlled 57 SPIRIT III 57 decitabine

Back to home page